Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Aripiprazole As A Depot Injection Suspension (atccode 2026-11-27
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Dimethyl Fumarate (atc Code 2026-11-27
Ireland Dynamic Purchasing System (dps) Invitation For The Supply Of Medical Gases, Services And Associated Products 2026-11-29
Germany Medicines Containing The Active Ingredient Filgrastim (atc: L03aa02) 2026-11-30
Germany Medicines Containing The Active Ingredient Secukinumab (atc: L04ac10) 2026-11-30
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Adalimumab (atc Code According To Who 2026-11-30
Germany Medicines Containing The Active Ingredient Epinephrine (atc 2026-11-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Acetylsalicylic Acid (b01ac06) Within The Framework Of A So-called Open-house Model. 2026-11-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products  2026-11-30
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Dornase Alfa (r05cb13) Within The Framework Of A So-called Open-house Model. 2026-11-30
Whats app